Copyright Reports & Markets. All rights reserved.

Global and China Crohn's Disease Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Crohn's Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Blood Tests
    • 1.2.3 Fecal Test
    • 1.2.4 Colonoscopy
    • 1.2.5 Flexible Sigmoidoscopy
    • 1.2.6 Computerized Tomography
    • 1.2.7 Magnetic Resonance Imaging
    • 1.2.8 Capsule Endoscopy
  • 1.3 Market by Application
    • 1.3.1 Global Crohn's Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
    • 1.3.2 Clinic
    • 1.3.3 Hospital
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Crohn's Disease Diagnostic and Therapeutic Market Perspective (2015-2026)
  • 2.2 Global Crohn's Disease Diagnostic and Therapeutic Growth Trends by Regions
    • 2.2.1 Crohn's Disease Diagnostic and Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Crohn's Disease Diagnostic and Therapeutic Historic Market Share by Regions (2015-2020)
    • 2.2.3 Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Crohn's Disease Diagnostic and Therapeutic Players by Market Size
    • 3.1.1 Global Top Crohn's Disease Diagnostic and Therapeutic Players by Revenue (2015-2020)
    • 3.1.2 Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Players (2015-2020)
  • 3.2 Global Crohn's Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Crohn's Disease Diagnostic and Therapeutic Revenue
  • 3.4 Global Crohn's Disease Diagnostic and Therapeutic Market Concentration Ratio
    • 3.4.1 Global Crohn's Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Crohn's Disease Diagnostic and Therapeutic Revenue in 2019
  • 3.5 Key Players Crohn's Disease Diagnostic and Therapeutic Area Served
  • 3.6 Key Players Crohn's Disease Diagnostic and Therapeutic Product Solution and Service
  • 3.7 Date of Enter into Crohn's Disease Diagnostic and Therapeutic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Crohn's Disease Diagnostic and Therapeutic Breakdown Data by Type (2015-2026)

  • 4.1 Global Crohn's Disease Diagnostic and Therapeutic Historic Market Size by Type (2015-2020)
  • 4.2 Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2021-2026)

5 Crohn's Disease Diagnostic and Therapeutic Breakdown Data by Application (2015-2026)

  • 5.1 Global Crohn's Disease Diagnostic and Therapeutic Historic Market Size by Application (2015-2020)
  • 5.2 Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Crohn's Disease Diagnostic and Therapeutic Market Size (2015-2026)
  • 6.2 North America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
  • 6.3 North America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
  • 6.4 North America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Crohn's Disease Diagnostic and Therapeutic Market Size (2015-2026)
  • 7.2 Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
  • 7.3 Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
  • 7.4 Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Crohn's Disease Diagnostic and Therapeutic Market Size (2015-2026)
  • 8.2 China Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
  • 8.3 China Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
  • 8.4 China Crohn's Disease Diagnostic and Therapeutic Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Crohn's Disease Diagnostic and Therapeutic Market Size (2015-2026)
  • 9.2 Japan Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
  • 9.3 Japan Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
  • 9.4 Japan Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size (2015-2026)
  • 10.2 Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Company Details
    • 11.1.2 AbbVie Business Overview
    • 11.1.3 AbbVie Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.1.4 AbbVie Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020))
    • 11.1.5 AbbVie Recent Development
  • 11.2 Celgene Corporation
    • 11.2.1 Celgene Corporation Company Details
    • 11.2.2 Celgene Corporation Business Overview
    • 11.2.3 Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.2.4 Celgene Corporation Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.2.5 Celgene Corporation Recent Development
  • 11.3 Genetech
    • 11.3.1 Genetech Company Details
    • 11.3.2 Genetech Business Overview
    • 11.3.3 Genetech Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.3.4 Genetech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.3.5 Genetech Recent Development
  • 11.4 Janssen Biotech
    • 11.4.1 Janssen Biotech Company Details
    • 11.4.2 Janssen Biotech Business Overview
    • 11.4.3 Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.4.4 Janssen Biotech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.4.5 Janssen Biotech Recent Development
  • 11.5 Johnson & Johnson
    • 11.5.1 Johnson & Johnson Company Details
    • 11.5.2 Johnson & Johnson Business Overview
    • 11.5.3 Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.5.4 Johnson & Johnson Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.5.5 Johnson & Johnson Recent Development
  • 11.6 Pfizer
    • 11.6.1 Pfizer Company Details
    • 11.6.2 Pfizer Business Overview
    • 11.6.3 Pfizer Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.6.4 Pfizer Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.6.5 Pfizer Recent Development
  • 11.7 Prometheus Laboratories
    • 11.7.1 Prometheus Laboratories Company Details
    • 11.7.2 Prometheus Laboratories Business Overview
    • 11.7.3 Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.7.4 Prometheus Laboratories Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.7.5 Prometheus Laboratories Recent Development
  • 11.8 Salix Pharmaceuticals
    • 11.8.1 Salix Pharmaceuticals Company Details
    • 11.8.2 Salix Pharmaceuticals Business Overview
    • 11.8.3 Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.8.4 Salix Pharmaceuticals Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.8.5 Salix Pharmaceuticals Recent Development
  • 11.9 Takeda's Pharmaceutical
    • 11.9.1 Takeda's Pharmaceutical Company Details
    • 11.9.2 Takeda's Pharmaceutical Business Overview
    • 11.9.3 Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Introduction
    • 11.9.4 Takeda's Pharmaceutical Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020)
    • 11.9.5 Takeda's Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Crohn's Disease Diagnostic and Therapeutic Scope and Market Size
    Crohn's Disease Diagnostic and Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crohn's Disease Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Blood Tests
    Fecal Test
    Colonoscopy
    Flexible Sigmoidoscopy
    Computerized Tomography
    Magnetic Resonance Imaging
    Capsule Endoscopy

    Market segment by Application, split into
    Clinic
    Hospital

    Based on regional and country-level analysis, the Crohn's Disease Diagnostic and Therapeutic market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Crohn's Disease Diagnostic and Therapeutic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    AbbVie
    Celgene Corporation
    Genetech
    Janssen Biotech
    Johnson & Johnson
    Pfizer
    Prometheus Laboratories
    Salix Pharmaceuticals
    Takeda's Pharmaceutical

    Buy now